XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.24.2

Note 8 - Financial Instruments With Off-balance-sheet Risk (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Notes Tables |
Schedule of Fair Value, off-Balance-Sheet Risks [Table Text Block] |
|  | June 30, 2024 |  |  | December 31, 2023 |
|  |  |  |  |  | Fair Value of |  |  |  |  |  |  | Fair Value of |
|  |  |  |  |  | Unfunded |  |  |  |  |  |  | Unfunded |
|  | Commitment |  |  | Commitment |  |  | Commitment |  |  | Commitment |
|  | Amount |  |  | Liability |  |  | Amount |  |  | Liability |
|  | (In thousands) |  |  | (In thousands) |
Better Place Forests Co. |  | $ | 1,500 |  |  | $ | — |  |  | $ | — |  |  |  | — |
BrightInsight, Inc. |  |  | 10,000 |  |  |  | 132 |  |  |  | 15,500 |  |  | $ | 241 |
Britecore Holdings, Inc. |  |  | 2,500 |  |  |  | 36 |  |  |  | 5,000 |  |  |  | 72 |
Candesant Biomedical Corporation |  |  | 10,000 |  |  |  | 151 |  |  |  | 10,000 |  |  |  | 151 |
Ceribell, Inc. |  |  | 21,000 |  |  |  | 120 |  |  |  | — |  |  |  | — |
Divergent Technologies, Inc. |  |  | — |  |  |  | — |  |  |  | 11,250 |  |  |  | 118 |
Elligo Healthcare Research, Inc. |  |  | 15,000 |  |  |  | 194 |  |  |  | 15,000 |  |  |  | 194 |
MicroTransponder, Inc. |  |  | 22,500 |  |  |  | — |  |  |  | 22,500 |  |  |  | — |
Mirantis, Inc. |  |  | 15,000 |  |  |  | 136 |  |  |  | 15,000 |  |  |  | 136 |
Optoro, Inc. |  |  | — |  |  |  | — |  |  |  | 6,250 |  |  |  | — |
Parse Biosciences, Inc. |  |  | 15,000 |  |  |  | 251 |  |  |  | 15,000 |  |  |  | 251 |
SafelyYou, Inc. |  |  | 10,000 |  |  |  | 147 |  |  |  | 20,000 |  |  |  | 270 |
Sonex Health, Inc. |  |  | — |  |  |  | — |  |  |  | 15,000 |  |  |  | 176 |
Standvast Holdings, LLC |  |  | 5,000 |  |  |  | 175 |  |  |  |  |  |  |  |  |
Supply Network Visibility Holdings, LLC |  |  | 5,000 |  |  |  | 17 |  |  |  | 10,000 |  |  |  | 35 |
Tallac Therapeutics, Inc. |  |  | 5,000 |  |  |  | 115 |  |  |  | 10,000 |  |  |  | 229 |
Viken Detection Corporation |  |  | — |  |  |  | — |  |  |  | 10,000 |  |  |  | 160 |
Total |  | $ | 137,500 |  |  | $ | 1,474 |  |  | $ | 180,500 |  |  | $ | 2,033 |

X
- Definition Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined) which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration